Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Medigen Biotechnology Corp (3176) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011108
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. ’s subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp.; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.

Medigen Biotechnology Corp (3176) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medigen Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigen Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigen Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigen Biotechnology Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Medigen Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigen Biotechnology Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Medigen Biotech Acquires B-cell Immortalization Platform Technology 10
Partnerships 11
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 11
Equity Offering 12
Medigen Biotech Completes Public Offering Of Shares For US$4 Million 12
Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 13
Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 14
Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 15
Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 16
Acquisition 17
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 17
Medigen Biotech Acquires Remaining Stake In Texas BioGene 19
Medigen Biotechnology Corp – Key Competitors 20
Medigen Biotechnology Corp – Key Employees 21
Medigen Biotechnology Corp – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Strategy And Business Planning 23
Nov 23, 2016: Medigen Vaccine Biologics’s Inaugurates Taiwan’s First Cell-Based Vaccine Manufacturing Plant 23
Corporate Communications 24
Jan 22, 2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Medigen Biotechnology Corp, Medical Equipment, Key Facts, 2015 2
Medigen Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Medigen Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigen Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigen Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigen Biotechnology Corp, Deals By Market, 2011 to YTD 2017 8
Medigen Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigen Biotech Acquires B-cell Immortalization Platform Technology 10
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 11
Medigen Biotech Completes Public Offering Of Shares For US$4 Million 12
Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 13
Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 14
Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 15
Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 16
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 17
Medigen Biotech Acquires Remaining Stake In Texas BioGene 19
Medigen Biotechnology Corp, Key Competitors 20
Medigen Biotechnology Corp, Key Employees 21
Medigen Biotechnology Corp, Other Locations 22
Medigen Biotechnology Corp, Subsidiaries 22

★海外企業調査レポート[Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Infineon Technologies AG (IFX):企業の財務・戦略的SWOT分析
    Infineon Technologies AG (IFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Verona Pharma Plc (VRP)-製薬・医療分野:企業M&A・提携分析
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Odebrecht S.A.:企業の戦略・SWOT・財務情報
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • KAMCO Investment Co KSCP (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Co KSCP (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • AF AB (AF B)-エネルギー分野:企業M&A・提携分析
    Summary AF AB is an engineering and consulting company. It offers various services such as product development and IT support to sectors including automotive, telecom, defense and life sciences. The company also provides services such as communications systems management, development of customized b …
  • Absorption Systems LP-医療機器分野:企業M&A・提携分析
    Summary Absorption Systems LP (Absorption Systems) is a pre-clinical contract research organization that develops and implements research tools. The organization carries out preclinical testing of drugs, biologics, and medical devices. It develops and implements research tools to predict human outco …
  • NEC Corporation:企業の戦略・SWOT・財務分析
    NEC Corporation - Strategy, SWOT and Corporate Finance Report Summary NEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PPL Corporation (PPL)-エネルギー分野:企業M&A・提携分析
    Summary PPL Corporation (PPL) is a utility company, which manages and operates electricity and natural gas businesses through its subsidiaries. It has presence in electric vertical from generation through transmission and distribution to energy retail. The company generates electricity from coal, na …
  • Sequana Medical AG-医療機器分野:企業M&A・提携分析
    Summary Sequana Medical AG (Sequana Medical), formerly NovaShunt AG is a medical device company that develops, manufactures and commercializes automated implantable pump systems to monitor fluid balance within the body. The company provides solution to manage ascites, which can occur as a symptom of …
  • Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析
    Summary Chinese Academy of Sciences (CAS) is a research institute that provides advisory and appraisal services on issues arising from the national economy, social development, and science and technology progress. The institute offers services such as applied research, basic research, experimental d …
  • Valener Inc (VNR):企業の戦略的SWOT分析
    Valener Inc (VNR) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Aboitiz Power Corporation (AP):電力:M&Aディール及び事業提携情報
    Summary Aboitiz Power Corporation (Aboitiz Power) a subsidiary of Aboitiz Equity Ventures Inc is a holding company that operates privately-owned generation companies and distribution utilities. Its power generation portfolio sources include hydropower, geothermal, coal, and oil. The company sells it …
  • Cargolux Airlines International SA:企業の戦略的SWOT分析
    Cargolux Airlines International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Public Bank Berhad:戦略・SWOT・企業財務分析
    Public Bank Berhad - Strategy, SWOT and Corporate Finance Report Summary Public Bank Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Motus Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motus Therapeutics Inc (Motus), formerly Rhythm Pharmaceuticals, Inc. is a subsidiary of Rhythm Holding Company LLC, biotechnology company that provides therapies. The company develops peptide therapeutics for the treatment of metabolic diseases. Its products under clinical development inclu …
  • Arcam AB:企業の戦略的SWOT分析
    Arcam AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Universal Music Group:企業の戦略的SWOT分析
    Universal Music Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oncolytics Biotech Inc (ONC)-医療機器分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Alliance Pharma Plc (APH):製薬・医療:M&Aディール及び事業提携情報
    Summary Alliance Pharma Plc (Alliance) is a specialty pharmaceutical company. It focuses on acquisition, licensing, registration and marketing of pharmaceutical products. It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervou …
  • Ambac Financial Group Inc (AMBC):企業の財務・戦略的SWOT分析
    Ambac Financial Group Inc (AMBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆